EUVIMEDEUVIMED entdecken
Crossref

Deciphering the Comprehensive Structure–Activity Relationship of Sunshinamide for Breast Cancer Therapy through Dual Modulation of Apoptotic and Ferroptotic Pathways via TrxR1 and Gpx4 Inhibition

Akash Chatterjee, Joyanta Mondal, Subhojit Paul, Himangshu Sharma iD, Rajib Kumar Goswami iD, Prosenjit Sen iD

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.4c01902 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Akash Chatterjee und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences, Indian Association for the Cultivation of Science, Jadavpur, Kolkata 700032, India. Hauptthemen laut MEDLINE: Apoptosis, Breast Neoplasms, Ferroptosis, Phospholipid Hydroperoxide Glutathione Peroxidase. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Science and Engineering Research Board, Indian Association for the Cultivation of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sunshinamide, a cyclodepsipeptide, has demonstrated significant potential in inhibiting cancer cell proliferation. Our prior research established the total synthesis and anticancer properties of sunshinamide. However, a deeper understanding of the structure-activity relationship (SAR) of sunshinamide remained imperative. In this study, we aimed to elucidate the SAR and mechanistic insights underlying sunshinamide action, both in vitro and in vivo. SAR studies confirm the crucial roles of both the bicyclic-ring and disulfide moiety in the anticancer activity of sunshinamide. Our recent findings unveil that sunshinamide targets TrxR1, leading to ROS generation and ER-stress-mediated apoptosis, while also promoting lipid peroxidation by targeting Gpx4, rendering cancer cells vulnerable to ferroptosis. In vivo, experiments demonstrated the effectiveness of sunshinamide in reducing tumor growth by inducing both apoptosis and ferroptosis. The dual efficacy of sunshinamide in eliciting apoptosis and ferroptosis positions it as a promising candidate for breast cancer therapy, addressing the challenge of chemoresistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisBreast NeoplasmsFerroptosisPhospholipid Hydroperoxide Glutathione PeroxidaseAntineoplastic AgentsThioredoxin Reductase 1HumansStructure-Activity RelationshipFemaleAnimalsMiceCell Line, TumorDepsipeptidesCell ProliferationMice, Inbred BALB CMice, Nude

Substanzen

Phospholipid Hydroperoxide Glutathione PeroxidaseAntineoplastic AgentsThioredoxin Reductase 1TXNRD1 protein, humanDepsipeptides

Autor:innen und Institutionen

  • School of Biological Sciences, Indian Association for the Cultivation of Science, Jadavpur, Kolkata 700032, India.
  • School of Chemical Sciences, Indian Association for the Cultivation of Science, Jadavpur, Kolkata 700032, India.

ORCID-Profile: Himangshu Sharma, Rajib Kumar Goswami, Prosenjit Sen

Förderung

  • Science and Engineering Research Board
  • Indian Association for the Cultivation of Science

Zitieren

APA

Chatterjee, A., Mondal, J., Paul, S., Sharma, H., Goswami, R. K., & Sen, P. (2024). Deciphering the Comprehensive Structure–Activity Relationship of Sunshinamide for Breast Cancer Therapy through Dual Modulation of Apoptotic and Ferroptotic Pathways via TrxR1 and Gpx4 Inhibition. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01902

Vancouver

Chatterjee A, Mondal J, Paul S, Sharma H, Goswami RK, Sen P. Deciphering the Comprehensive Structure–Activity Relationship of Sunshinamide for Breast Cancer Therapy through Dual Modulation of Apoptotic and Ferroptotic Pathways via TrxR1 and Gpx4 Inhibition. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c01902

BibTeX
@article{Chatterjee2024,
  author = {Chatterjee, Akash and Mondal, Joyanta and Paul, Subhojit and Sharma, Himangshu and Goswami, Rajib Kumar and Sen, Prosenjit},
  title = {Deciphering the Comprehensive Structure–Activity Relationship of Sunshinamide for Breast Cancer Therapy through Dual Modulation of Apoptotic and Ferroptotic Pathways via TrxR1 and Gpx4 Inhibition},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c01902}
}
Kostenlos starten →